跳至主要内容
临床试验/IRCT2013052313427N1
IRCT2013052313427N1已完成未知

The efficacy of Omega3 in treatment of Non-Alcoholic Fatty Liver Disease

Fasa University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • The patient who diagnosed as fatty liver disease by increase in ALT and AST and liver ultrasonography with 4 criteria of sonography added to intervention.The patient who hasn't sign the permission form, or drink ethanol more than 20 gram in a day or take some drugs that cause of fatty liver such as steroids,sterogen,amiodaron,tamoxifen in 6 month ago and patient who has Hepatit B and C,auto immune hepatitis, wilson, hemachromatosis, decrease of alpha-1-antitripsin or sever disease such as heart, liver, psychology disease was eliminated.

排除标准

  • 未提供

研究者

发起方
Fasa University of Medical Sciences

相似试验